| |
|
|
|
|
|
|
|||
|
Blood, 15 June 2006, Vol. 107, No. 12, pp. 4865-4870. Prepublished online as a Blood First Edition Paper on March 9, 2006; DOI 10.1182/blood-2005-07-2820.
Submitted July 15, 2005
Department of General Internal Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; Nijmegen University Centre for Infectious Diseases, Nijmegen, The Netherlands * Corresponding author; email: m.vandeuren{at}aig.umcn.nl.
The complement system is an essential element in our innate defense against infections with N. meningitidis. We describe two cases of meningococcal septic shock, one of them fatal, in two children of a Turkish family. In the surviving patient, alternative pathway activation was absent and factor D plasma concentrations were undetectable. Concentration of MBL, C1q, C4 and C3, Factor B, Properdine, factor H and I were normal. Mutation analysis of the factor D gene revealed a T638 >G (Val213 >Gly) and a T640 >C (Cys 214>Arg) mutation in the genomic DNA from the patient, both in homozygous form. The consanguineous parents and an unaffected sister had these mutations in heterozygous form. In vitro incubation of factor-D-deficient plasma of the boy with serogroup B N. meningitidis, showed normal MBL-mediated complement activation but no formation of the alternative pathway C3-convertase C3bBbP, and severely decreased C3bc formation and terminal complement activation. The defect was restored after supplementation with factor D. In conclusion, this is the second report of a factor D gene mutation leading to factor D deficiency in a family with meningococcal disease. This deficiency abolishes alternative-pathway dependent complement activation by N. meningitidis, and leads to an increased susceptibility to invasive meningococcal disease.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||